Company
Nitinotes
First Approved Automated ESG Suturing System for Obesity
Also known as Nitinotes LTD
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Caesarea, Israel
- Legal name
- Nitinotes LTD
- nitinotesurgical.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 20 September 2026
About
Nitinotes is an early-commercial stage medical device company based in Caesarea, Israel. Its flagship product EndoZip™, is a novel automated endoscopic suturing system for safer and simpler gastroscopic restriction for the treatment of obesity.
Funding snapshot
- Total raised
- $26.5MSum of rounds, as of 2026-09-20Source (opens in a new tab)
- Latest round
- Safe, $9.3M2024-12-23
Funding rounds
- Safe
- $9.3M2024-12-23, Company stated
- Series B
- $10.1M2023-09-28, Company stated
- Series A
- $7.1M2020-05-10, Company stated
Products
- Hardware
- EndoZip™
Loading relationship preview